Profile | GDS4284 / 223403_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2117.36 | 84 |
GSM687648 | Patient 402 control | 1636.47 | 81 |
GSM687653 | Patient 403 control | 1731.93 | 82 |
GSM687658 | Patient 404 control | 1379.45 | 79 |
GSM687663 | Patient 411 control | 1594.96 | 81 |
GSM687668 | Patient 422 control | 1897.51 | 83 |
GSM687673 | Patient 424 control | 1953.48 | 84 |
GSM687678 | Patient 425 control | 1821.81 | 82 |
GSM687683 | Patient 427 control | 1416.83 | 79 |
GSM687688 | Patient 428 control | 2059.64 | 84 |
GSM687695 | Patient 441 control | 1454.61 | 81 |
GSM687699 | Patient 443 control | 1478.41 | 80 |
GSM687704 | Patient 444 control | 2074.73 | 84 |
GSM687707 | Patient 448 control | 1969.15 | 84 |
GSM687712 | Patient 449 control | 1455.52 | 80 |
GSM687719 | Patient 450 control | 1805.24 | 83 |
GSM687724 | Patient 451 control | 1911.14 | 84 |
GSM687728 | Patient 452 control | 1258.78 | 78 |
GSM687646 | Patient 401 treated 24h | 1607.83 | 80 |
GSM687649 | Patient 402 treated 24h | 1515.34 | 80 |
GSM687665 | Patient 411 treated 24h | 1647.52 | 81 |
GSM687651 | Patient 402 treated 4 weeks | 1696.84 | 81 |
GSM687667 | Patient 411 treated 4 weeks | 1815.98 | 82 |
GSM687670 | Patient 422 treated 24h | 1577.08 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 2099.76 | 84 |
GSM687654 | Patient 403 treated 24h | 1819.81 | 83 |
GSM687675 | Patient 424 treated 24h | 2252.82 | 85 |
GSM687685 | Patient 427 treated 24h | 1276 | 77 |
GSM687656 | Patient 403 treated 4 weeks | 1931.05 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 1933.07 | 83 |
GSM687687 | Patient 427 treated 4 weeks | 1445.5 | 79 |
GSM687692 | Patient 428 treated 4h | 1708.51 | 82 |
GSM687716 | Patient 449 treated 4h | 1265.32 | 78 |
GSM687722 | Patient 450 treated 4h | 1622.91 | 81 |
GSM687680 | Patient 425 treated 24h | 1945.15 | 83 |
GSM687690 | Patient 428 treated 24h | 2031.39 | 84 |
GSM687700 | Patient 443 treated 24h | 1290.41 | 78 |
GSM687705 | Patient 444 treated 24h | 2514.46 | 87 |
GSM687714 | Patient 449 treated 24h | 1623.93 | 81 |
GSM687721 | Patient 450 treated 24h | 1648.44 | 82 |
GSM687682 | Patient 425 treated 4 weeks | 1733.24 | 82 |
GSM687694 | Patient 428 treated 4 weeks | 1986.56 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1668.95 | 81 |
GSM687718 | Patient 449 treated 4 weeks | 1486.84 | 80 |
GSM687723 | Patient 450 treated 4 weeks | 2079.94 | 85 |
GSM687661 | Patient 404 treated 4h | 1395.57 | 79 |
GSM687710 | Patient 448 treated 4h | 2230.26 | 85 |
GSM687726 | Patient 451 treated 4h | 1772.05 | 82 |
GSM687730 | Patient 452 treated 4h | 1271.84 | 78 |
GSM687660 | Patient 404 treated 24h | 1169.18 | 78 |
GSM687697 | Patient 441 treated 24h | 1278.12 | 78 |
GSM687709 | Patient 448 treated 24h | 2266.78 | 86 |
GSM687725 | Patient 451 treated 24h | 2108.33 | 85 |
GSM687729 | Patient 452 treated 24h | 1071.56 | 77 |
GSM687727 | Patient 451 treated 4 weeks | 1664.15 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 1697.68 | 82 |